Glaxo
This article was originally published in The Tan Sheet
Executive Summary
Former head of Glaxo's Canadian business Arthur Pappas is leaving the company "to provide independent financial and counseling activities in high technology industries," the firm reported. Pappas, who oversaw Glaxo's entry into the OTC market through a joint venture agreement with Warner-Lambert, resigned from the Glaxo board in February, when Robert Ingrain was promoted to the CEO spot